| JAK/STAT signaling in hepatocellular carcinoma JJ Hin Tang, DK Hao Thng, JJ Lim, TB Toh Hepatic oncology 7 (1), HEP18, 2020 | 98 | 2020 |
| Capitalizing on synthetic lethality of MYC to treat cancer in the digital age DKH Thng, TB Toh, EKH Chow Trends in pharmacological sciences 42 (3), 166-182, 2021 | 43 | 2021 |
| Targeted inhibition of purine metabolism is effective in suppressing hepatocellular carcinoma progression YC Chong, TB Toh, Z Chan, QXX Lin, DKH Thng, L Hooi, Z Ding, T Shuen, ... Hepatology communications 4 (9), 1362-1381, 2020 | 26 | 2020 |
| Enhanced penetrative siRNA delivery by a nanodiamond drug delivery platform against hepatocellular carcinoma 3D models J Xu, M Gu, L Hooi, TB Toh, DKH Thng, JJ Lim, EKH Chow Nanoscale 13 (38), 16131-16145, 2021 | 22 | 2021 |
| Histone‐lysine N‐methyltransferase EHMT2 (G9a) inhibition mitigates tumorigenicity in Myc‐driven liver cancer DKH Thng, L Hooi, CCM Toh, JJ Lim, D Rajagopalan, IQC Syariff, ZM Tan, ... Molecular Oncology 17 (11), 2275-2294, 2023 | 6 | 2023 |
| NanoBeacon. AI: AI-enhanced nanodiamond biosensor for automated sensitivity prediction to oxidative phosphorylation inhibitors J Xu, M Zheng, DKH Thng, TB Toh, L Zhou, GK Bonney, YY Dan, ... ACS sensors 8 (5), 1989-1999, 2023 | 4 | 2023 |
| Splice‐switch oligonucleotide‐based combinatorial platform prioritizes synthetic lethal targets CHK1 and BRD4 against MYC‐driven hepatocellular carcinoma DKH Thng, TB Toh, P Pigini, L Hooi, YY Dan, PKH Chow, GK Bonney, ... Bioengineering & Translational Medicine 8 (1), e10363, 2023 | 4 | 2023 |
| Abstract P43: Optimization of DNA Methyltransferase Inhibitors-based Combination to Target the Epigenome of Gastric Cancer L Hooi, V Koh, DKH Thng, J Goh, LJ Jieh, LR Xue, MBMA Rashid, ... Cancer Research 84 (8_Supplement), P43-P43, 2024 | | 2024 |
| Mechanistic insights and the clinical prospects of targeted therapies for glioblastoma: a comprehensive review Y Shen, DKH Thng, ALA Wong, TB Toh Experimental Hematology & Oncology 13 (1), 40, 2024 | | 2024 |
| A functional personalised oncology approach against metastatic colorectal cancer in matched patient derived organoids DKH Thng, L Hooi, BE Siew, KY Lee, IJW Tan, B Lieske, NS Lin, ... NPJ Precision Oncology 8 (1), 52, 2024 | | 2024 |
